148 related articles for article (PubMed ID: 8442432)
41. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
Camacho NP; Carroll P; Raggio CL
Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
[TBL] [Abstract][Full Text] [Related]
42. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.
Brenner RE; Vetter U; Bollen AM; Mörike M; Eyre DR
J Bone Miner Res; 1994 Jul; 9(7):993-7. PubMed ID: 7942168
[TBL] [Abstract][Full Text] [Related]
43. Intravenous pamidronate in osteogenesis imperfecta type VII.
Cheung MS; Glorieux FH; Rauch F
Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
[TBL] [Abstract][Full Text] [Related]
44. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy.
Camacho NP; Landis WJ; Boskey AL
Connect Tissue Res; 1996; 35(1-4):259-65. PubMed ID: 9084664
[TBL] [Abstract][Full Text] [Related]
45. Comparison of nanoindentation measurements between osteogenesis imperfecta Type III and Type IV and between different anatomic locations (femur/tibia versus iliac crest).
Fan Z; Smith PA; Harris GF; Rauch F; Bajorunaite R
Connect Tissue Res; 2007; 48(2):70-5. PubMed ID: 17453908
[TBL] [Abstract][Full Text] [Related]
46. A morphological and ultrastructural study of bone in osteogenesis imperfecta.
Cassella JP; Stamp TC; Ali SY
Calcif Tissue Int; 1996 Mar; 58(3):155-65. PubMed ID: 8852570
[TBL] [Abstract][Full Text] [Related]
47. Cross-link profile of bone collagen correlates with structural organization of trabeculae.
Banse X; Devogelaer JP; Lafosse A; Sims TJ; Grynpas M; Bailey AJ
Bone; 2002 Jul; 31(1):70-6. PubMed ID: 12110415
[TBL] [Abstract][Full Text] [Related]
48. Urinary Cross-linked N-terminal Telopeptide of Type I Collagen Levels of Infants with Osteogenesis Imperfecta and Healthy Infants.
Yamashita M; Hasegawa K; Higuchi Y; Miyai T; Okada A; Tanaka H; Tsukahara H
Acta Med Okayama; 2016 Dec; 70(6):435-439. PubMed ID: 28003667
[TBL] [Abstract][Full Text] [Related]
49. Ultrastructural localization of proteoglycans in bone in osteogenesis imperfecta as demonstrated by Cuprolinic Blue staining.
Sarathchandra P; Cassella JP; Ali SY
J Bone Miner Metab; 2002; 20(5):288-93. PubMed ID: 12203034
[TBL] [Abstract][Full Text] [Related]
50. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues.
Eyre DR; Dickson IR; Van Ness K
Biochem J; 1988 Jun; 252(2):495-500. PubMed ID: 3415669
[TBL] [Abstract][Full Text] [Related]
51. Osteogenesis imperfecta (lethal) bones contain types III and V collagens.
Pope FM; Nicholls AC; Eggleton C; Narcissi P; Hey EN; Parkin JM
J Clin Pathol; 1980 Jun; 33(6):534-8. PubMed ID: 7400355
[TBL] [Abstract][Full Text] [Related]
52. An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta.
Petrovic OM; Miller EJ
J Clin Invest; 1984 Jun; 73(6):1569-75. PubMed ID: 6427276
[TBL] [Abstract][Full Text] [Related]
53. Mechanical properties of OI type III bone tissue measured by nanoindentation.
Fan Z; Smith PA; Eckstein EC; Harris GF
J Biomed Mater Res A; 2006 Oct; 79(1):71-7. PubMed ID: 16758461
[TBL] [Abstract][Full Text] [Related]
54. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.
Cheung MS; Arponen H; Roughley P; Azouz ME; Glorieux FH; Waltimo-Sirén J; Rauch F
J Bone Miner Res; 2011 Feb; 26(2):405-13. PubMed ID: 20721936
[TBL] [Abstract][Full Text] [Related]
55. Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.
Gistelinck C; Witten PE; Huysseune A; Symoens S; Malfait F; Larionova D; Simoens P; Dierick M; Van Hoorebeke L; De Paepe A; Kwon RY; Weis M; Eyre DR; Willaert A; Coucke PJ
J Bone Miner Res; 2016 Nov; 31(11):1930-1942. PubMed ID: 27541483
[TBL] [Abstract][Full Text] [Related]
56. Concentration of collagen cross-links in human dentin bears no relation to the individual age.
Açil Y; Springer IN; Prasse JG; Hedderich J; Jepsen S
Int J Legal Med; 2002 Dec; 116(6):340-3. PubMed ID: 12461641
[TBL] [Abstract][Full Text] [Related]
57. Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen.
Trelstad RL; Rubin D; Gross J
Lab Invest; 1977 May; 36(5):501-8. PubMed ID: 865078
[TBL] [Abstract][Full Text] [Related]
58. Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue.
Nyman JS; Roy A; Acuna RL; Gayle HJ; Reyes MJ; Tyler JH; Dean DD; Wang X
Bone; 2006 Dec; 39(6):1210-7. PubMed ID: 16962838
[TBL] [Abstract][Full Text] [Related]
59. Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b.
Puzas JE; Brand JS; Jackman KV
Bone Miner; 1986 Oct; 1(5):373-82. PubMed ID: 2849487
[TBL] [Abstract][Full Text] [Related]
60. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
Fraser J; Lancaster GA; Scriver CR
Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
